Person profile
Address
Los Angeles, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Arcellx, Inc.
6 Jun 24
4
Contineum Therapeutics, Inc.
29 May 24
4
Revance Therapeutics, Inc.
3 May 24
4
Arcellx, Inc.
18 Apr 24
3
Contineum Therapeutics, Inc.
4 Apr 24
4
Arcellx, Inc.
18 Mar 24
144
Arcellx, Inc.
15 Mar 24
4
Arcellx, Inc.
16 Jun 23
4
Revance Therapeutics, Inc.
5 May 23
4
Arcellx, Inc.
17 May 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 May 24 | ACLX Arcellx | Stock Option Common Stock | Grant | Acquire A | No | No | 51.3 | 8,011 | 410.96 k | 8,011 |
24 May 24 | CTNM Contineum Therapeutics Inc. - Ordinary Shares | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 15.76 | 3,700 | 58.31 k | 3,700 |
1 May 24 | RVNC Revance Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 15,000 | 0.00 | 31,675 |
1 May 24 | RVNC Revance Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.795 | 23,458 | 89.02 k | 23,458 |
16 Apr 24 | ACLX Arcellx | Common Stock | Sell | Dispose S | No | Yes | 56.031 | 2,612 | 146.35 k | 0 |
16 Apr 24 | ACLX Arcellx | Common Stock | Sell | Dispose S | No | Yes | 55.3618 | 6,790 | 375.91 k | 2,612 |
16 Apr 24 | ACLX Arcellx | Common Stock | Option exercise | Acquire M | No | No | 7.61 | 9,402 | 71.55 k | 9,402 |
16 Apr 24 | ACLX Arcellx | Stock Option Common Stock | Option exercise | Dispose M | No | No | 7.61 | 9,402 | 71.55 k | 36,806 |